ε2 allele and ε2-involved genotypes (ε2/ε2, ε2/ε3, and ε2/ε4) may confer the association of APOE genetic polymorphism with risks of nephropathy in type 2 diabetes: a meta-analysis.

Lipids in Health and Disease
Jikang ShiYi Cheng

Abstract

Diabetic nephropathy (DN) contributes to end-stage renal failure. Microvascular injury resulted from reactive oxygen species is implicated in the pathogenesis of DN. Genetic polymorphism of Apolipoprotein E (APOE) influences the antioxidative properties of the protein. The relationship of APOE polymorphism with the risks of nephropathy in type 2 diabetes (T2DN) remains elusive. An up-to-date meta-analysis was conducted on the basis of studies selected from PubMed, WanFang database, Embase, Vip database, Web of Science, Scopus, and CNKI database. A total of 33 studies conferring 3266 cases and 3259 controls were selected on the basis of criteria of inclusion and exclusion in this meta-analysis. For APOE alleles, the pooled odds ratio (OR) of ε2 vs. ε3 was 1.89 (95% confidence intervals [95% CI]: 1.49-2.38, P < 0.0001). With regard to APOE genotypes, ε2/ε2, ε2/ε3, and ε2/ε4 increased the risk of T2DN (ε2/ε2 vs. ε3/ε3: OR = 2.32, 95% CI: 1.52-3.56, P = 0.0001; ε2/ε3 vs. ε3/ε3: OR = 1.97, 95% CI: 1.50-2.59, P<0.0001; ε2/ε4 vs. ε3/ε3: OR = 1.69, 95% CI: 1.18-2.44, P = 0.0046). This meta-analysis found that the APOE ε2 allele and the ε2-involved genotypes (ε2/ε2, ε2/ε3, and ε2/ε4) are the risk factors of T2DN.

References

Apr 8, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·H KimuraM Arakawa
Sep 17, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·S K HaD S Han
Jan 23, 2003·Journal of the American Society of Nephrology : JASN·Moriz BuzelloKerstin Amann
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Aug 18, 2004·Trends in Genetics : TIG·Marcus R Munafò, Jonathan Flint
Dec 24, 2004·Diabetes Care·Jorge L GrossThemis Zelmanovitz
Aug 26, 2006·Cell Biochemistry and Function·Necip IlhanRamis Colak
May 8, 2007·Diabetes Research and Clinical Practice·Elba LeivaMiguel Arredondo
Jan 19, 2008·Molecular Nutrition & Food Research·Laia Jofre-MonsenyGerald Rimbach
Feb 17, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jing GuanJuliana C N Chan
Feb 24, 2010·Molecular Biology Reports·Yang LiChunling Wan
Jan 9, 2013·Nature Reviews. Neurology·Chia-Chen LiuGuojun Bu
Sep 13, 2013·Clinical and Experimental Nephrology·Shin-ichi Araki
Dec 3, 2013·Current Diabetes Reports·Helen Vlassara, Jaime Uribarri
Dec 29, 2013·Journal of Lipid Research·Michal Herman-EdelsteinUzi Gafter
Sep 10, 2014·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Yi-jin LinYao-jun Wu
Apr 30, 2015·American Journal of Physiology. Endocrinology and Metabolism·Yang ZhangBi Cheng Liu
Dec 15, 2015·IUBMB Life·Mohamed I AttaNabil F Zaher
Aug 16, 2016·Journal of Diabetes Research·Alejandra Guillermina Miranda-DíazJorge Andrade-Sierra
Mar 8, 2017·BMC Medical Research Methodology·Jørn WetterslevChristian Gluud
Sep 25, 2017·Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia·Mostafa KarimoeiFarideh Razi
Jan 27, 2018·Cell Death & Disease·Caroline Maria Oliveira VolpeJosé Augusto Nogueira-Machado
Dec 24, 2018·Kidney Diseases·Ling WeiLin Sun

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
chip

Software Mentioned

TSA
Scopus
R Studio

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.